
Greg Medlock
@MedlockGreg
Followers
131
Following
372
Media
4
Statuses
80
Sr Director R&D @vedantabio. Interested in drug development, infection prevention, microbiome, systems biology, & urban policy. On Bsky now.
Cambridge, MA
Joined May 2023
RT @CARB_X: It’s World AMR Awareness Week! Watch the video below to hear CARB-X Chief of R&D Erin Duffy highlight the progress of the portf….
0
2
0
RT @PearlF: If you're following biotech news & starting to become more active on Bluesky, one suggestion I have is @TheCrick's @simonbayly….
0
1
0
RT @biorxiv_micrbio: Phenotypic high-throughput screening identifies modulators of gut microbial choline metabolism .
0
2
0
RT @john_damianosMD: Is the future of inflammatory bowel disease therapy immune therapy plus #microbiome therapy? . Here is a patient with….
0
15
0
My team at @VedantaBio is recruiting a molecular biologist to work on development and qualification of assays for characterizing defined bacterial consortia. Please share with your network and consider applying!.
0
3
3
Barely a week after John Corcoran was killed when a driver hopped the curb on @MassDCR-managed Memorial Drive and hit him on the sidewalk, @MassGov retweeted this.
October is #PedestrianSafetyMonth and we want to share some important traits that #Pedestrians everywhere should have while interacting with traffic! #PedestrianSafety matters! Let's stay safe and alert! #TrafficSafety #EndTheStreakTX 🦖🚶♂️ Thank you @txdot for these reminders!
0
0
2
Great seeing @bernatolle finally chatting with @bradloncar !.
𝐓𝐚𝐥𝐤𝐢𝐧𝐠 𝐒𝐜𝐢𝐞𝐧𝐜𝐞: @VedantaBio's founder and CEO @bernatolle shares an expert take on microbiome drug development. Full video:
0
0
6
RT @biorxiv_micrbio: Long-read metagenomics empowers precise tracking of bacterial strains and their genomic changes after fecal microbiota….
0
2
0
The Microbiome Therapeutic Innovation Group @MTIG_News members recently came together to write this minireview highlighting regulatory and analytical challenges in LBP development. This is a helpful primer for academics and early-stage microbiome therapeutics developers.
New Research: Navigating regulatory and analytical challenges in live biotherapeutic product development and manufacturing #FrontiersIn #Microbiomes.
0
0
3
RT @PeggyFund: After months of hard work and collaboration, Congresswoman Yvette D. Clarke introduced the Peggy Lillis Clostridioides diffi….
0
4
0
Great opportunity to learn more about C. difficile infection and microbiome-based therapies.
Registration now open for the Scientific Symposium debuting on 11/15/2024. This virtual event will allow clinicians, scientists, nurses, pharmacists, and industry to intermingle and update each other during C. diff Awareness Month. Register for free here
0
0
0
RT @jsauce7: Open positions in physiology and biophysics @MedicineUVA. Great interdisciplinary science, collaborations, and hiking @Shenand….
0
2
0
Very excited to be in Rome at #IHMC2024 representing @VedantaBio. This morning I will share updates related to our VE303 program, for which we recently recruited our first patient in a phase 3 pivotal trial. Please say hi to me or @awatsontxt to learn more about Vedanta!
0
1
14